PPT1 and infection: We therefore reasoned that ERT, with its potential to treat the PPT1-deficient CNS, could represent a means to rapid and potentially more effective translation, despite potential challenges such as the need for repeated enzyme delivery, the attendant risk of port-associated infections, and potential immune responses to the exogenous protein (3, 32, 33).